Xenon Pharmaceuticals Inc. (XENE): Price and Financial Metrics
Xenon Pharmaceuticals Inc. (XENE)
Today's Latest Price: $9.72 USD
Updated Oct 30 4:00pm
Add XENE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
XENE Stock Summary
- The ratio of debt to operating expenses for Xenon Pharmaceuticals Inc is higher than it is for about only 5.23% of US stocks.
- With a year-over-year growth in debt of -94.42%, Xenon Pharmaceuticals Inc's debt growth rate surpasses merely 1.58% of about US stocks.
- As for revenue growth, note that XENE's revenue has grown 299.63% over the past 12 months; that beats the revenue growth of 97.86% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Xenon Pharmaceuticals Inc are NXTC, VBLT, NTLA, FULC, and KALV.
- XENE's SEC filings can be seen here. And to visit Xenon Pharmaceuticals Inc's official web site, go to www.xenon-pharma.com.
XENE Stock Price Chart Interactive Chart >
XENE Price/Volume Stats
| Current price | $9.72 | 52-week high | $18.45 |
| Prev. close | $9.62 | 52-week low | $7.00 |
| Day low | $9.32 | Volume | 149,900 |
| Day high | $10.16 | Avg. volume | 201,932 |
| 50-day MA | $11.20 | Dividend yield | N/A |
| 200-day MA | $12.54 | Market Cap | 340.15M |
Xenon Pharmaceuticals Inc. (XENE) Company Bio
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing differentiated therapeutics for orphan indications in Canada. The company was founded in 1996 and is based in Burnaby, Canada.
Loading social stream, please wait...